The New York State Medical Marijuana Program

Guidance on Use of Vaping Products for Medical Marijuana Patients

成人香蕉视频appThe NYS Department of Health urges all New Yorkers to stop using vape products until the definitive cause of reported vaping-associated serious pulmonary (lung) illnesses nationwide can be better determined. Since the investigation into the illnesses began, there have been no reports of adverse events associated with approved products in the NYS Medical Marijuana Program related to the outbreak. Medical marijuana products are approved by the Department and rigorously tested for contaminants, pesticides and concentration of cannabinoids, including, but not limited to Tetrahydrocannabinol (THC) and Cannabidiol (CBD). However, out of an abundance of caution, we are also urging patients in the medical marijuana program to consult with their health care providers on potential alternatives to vaping products while the investigation continues.

For more information about vaping-associated illnesses, click here.

Medicaid Policy Clarification Issued Regarding Coverage for Office Visits Related to Medical Marijuana:

成人香蕉视频appMedical marijuana products are not a covered benefit under New York State Medicaid. However, practitioner office visits related to patient evaluation and certification for medical marijuana is a Medicaid reimbursable service. Practitioners are prohibited from requesting payment for medical marijuana certification from the member, regardless whether the certification is provided during the initial office visit or subsequent to the initial visit.

Further details on this covered benefit can be accessed from the following link: Policy Clarification – Medical Marijuana

NEW! Provider Education Applications Being Accepted

Individuals or organizations that offer medical marijuana educational courses for health care providers and are interested in offering those courses through the NYS Medical Marijuana Program can find more information here.

Department of Financial Services (DFS) Guidance to Health Insurers Regarding Coverage for Office Visits Related to Medical Marijuana

The New York State Department of Financial Services (DFS) recently issued guidance to health insurers regarding coverage for office visits related to medical marijuana. The guidance from DFS may be accessed by clicking on the following link: (PDF)

  • November 14, 2018: Medical Use of Marijuana Under the Compassionate Care Act Two-year Report - 2016-2018 (PDF)
  • July 12, 2018: New York State Department of Health Announces Opioid Replacement Now a Qualifying Condition for Medical Marijuana
  • June 18, 2018 - New York State Department of Health Announces Opioid Use to be Added as a Qualifying Condition for Medical Marijuana
  • December 8, 2017 – New York State Department of Health Announces New Medical Marijuana Regulations
  • August 10, 2017 - New York State Department of Health Announces New Regulations to Improve State's Medical Marijuana Program for Patients, Practitioners, and Registered Organizations
  • August 1, 2017 - New York State Department of Health Adds Five New Registered Organizations to Medical Marijuana Program
  • June 22, 2017 - New York State Department of Health Announces Enhancements to Medical Marijuana Program
  • May 5, 2017 - New York State Department of Health Adds Thousands of New Patients to Medical Marijuana Program Following the Addition of Chronic Pain
  • December 1, 2016 - NYSDOH Announces Chronic Pain to Be Added As Qualifying Condition for Medical Marijuana
  • November 22, 2016 - NYSDOH Announces Expansion of Medical Marijuana Program